Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation

Anne S. Tsao; O. Wolf Lindwasser; Alex A. Adjei; Prasad S. Adusumilli; Matthew L. Beyers; Gideon M. Blumenthal; Raphael Bueno; Bryan M. Burt; Michele Carbone; Suzanne E. Dahlberg; Marc de Perrot; Dean A. Fennell; Joseph Friedberg; Ritu R. Gill; Daniel R. Gomez; David H. Harpole; Raffit Hassan; Mary Hesdorffer; Fred R. Hirsch; Julija Hmeljak; Hedy L. Kindler; Edward L. Korn; Geoffrey Liu; Aaron S. Mansfield; Anna K. Nowak; Harvey I. Pass; Tobias Peikert; Andreas Rimner; Bruce W.S. Robinson; Kenneth E. Rosenzweig; Valerie W. Rusch; Ravi Salgia; Boris Sepesi; Charles B. Simone; Rajeshwari Sridhara; Peter Szlosarek; Emanuela Taioli; Ming Sound Tsao; Haining Yang; Marjorie G. Zauderer; Shakun M. Malik

doi:10.1016/j.jtho.2018.08.2036

Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation

Anne S. Tsao
, O. Wolf Lindwasser
, Alex A. Adjei
, Prasad S. Adusumilli
, Matthew L. Beyers
, Gideon M. Blumenthal
, Raphael Bueno
, Bryan M. Burt
, Michele Carbone
, Suzanne E. Dahlberg
, Marc de Perrot
, Dean A. Fennell
, Joseph Friedberg
, Ritu R. Gill
, Daniel R. Gomez
, David H. Harpole
, Raffit Hassan
, Mary Hesdorffer
, Fred R. Hirsch
, Julija Hmeljak

Hedy L. Kindler, Edward L. Korn, Geoffrey Liu, Aaron S. Mansfield, Anna K. Nowak, Harvey I. Pass, Tobias Peikert, Andreas Rimner, Bruce W.S. Robinson, Kenneth E. Rosenzweig, Valerie W. Rusch, Ravi Salgia, Boris Sepesi, Charles B. Simone, Rajeshwari Sridhara, Peter Szlosarek, Emanuela Taioli, Ming Sound Tsao, Haining Yang, Marjorie G. Zauderer, Shakun M. Malik

Research output: Contribution to journal › Article › peer-review

100 Scopus citations

Abstract

On March 28– 29, 2017, the National Cancer Institute (NCI) Thoracic Malignacy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation convened the NCI–International Association for the Study of Lung Cancer– Mesothelioma Applied Research Foundation Mesothelioma Clinical Trials Planning Meeting in Bethesda, Maryland. The goal of the meeting was to bring together lead academicians, clinicians, scientists, and the U.S. Food and Drug Administration to focus on the development of clinical trials for patients in whom malignant pleural mesothelioma has been diagnosed. In light of the discovery of new cancer targets affecting the clinical development of novel agents and immunotherapies in malignant mesothelioma, the objective of this meeting was to assemble a consensus on at least two or three practice-changing multimodality clinical trials to be conducted through NCI's National Clinical Trials Network.

Original language	English
Pages (from-to)	1655-1667
Number of pages	13
Journal	Journal of Thoracic Oncology
Volume	13
Issue number	11
DOIs	https://doi.org/10.1016/j.jtho.2018.08.2036
State	Published - Nov 2018

Keywords

Clinical trials
Malignant mesothelioma
Multimodality therapy
Pleural
Targeted therapy

Access to Document

10.1016/j.jtho.2018.08.2036

Fingerprint

Dive into the research topics of 'Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation'. Together they form a unique fingerprint.

Cite this

Tsao, A. S., Lindwasser, O. W., Adjei, A. A., Adusumilli, P. S., Beyers, M. L., Blumenthal, G. M., Bueno, R., Burt, B. M., Carbone, M., Dahlberg, S. E., de Perrot, M., Fennell, D. A., Friedberg, J., Gill, R. R., Gomez, D. R., Harpole, D. H., Hassan, R., Hesdorffer, M., Hirsch, F. R., ... Malik, S. M. (2018). Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation. Journal of Thoracic Oncology, 13(11), 1655-1667. https://doi.org/10.1016/j.jtho.2018.08.2036

Tsao, Anne S. ; Lindwasser, O. Wolf ; Adjei, Alex A. et al. / Current and Future Management of Malignant Mesothelioma : A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation. In: Journal of Thoracic Oncology. 2018 ; Vol. 13, No. 11. pp. 1655-1667.

@article{8200f35468eb4d63b7974ce8be714709,

title = "Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation",

abstract = "On March 28– 29, 2017, the National Cancer Institute (NCI) Thoracic Malignacy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation convened the NCI–International Association for the Study of Lung Cancer– Mesothelioma Applied Research Foundation Mesothelioma Clinical Trials Planning Meeting in Bethesda, Maryland. The goal of the meeting was to bring together lead academicians, clinicians, scientists, and the U.S. Food and Drug Administration to focus on the development of clinical trials for patients in whom malignant pleural mesothelioma has been diagnosed. In light of the discovery of new cancer targets affecting the clinical development of novel agents and immunotherapies in malignant mesothelioma, the objective of this meeting was to assemble a consensus on at least two or three practice-changing multimodality clinical trials to be conducted through NCI's National Clinical Trials Network.",

keywords = "Clinical trials, Malignant mesothelioma, Multimodality therapy, Pleural, Targeted therapy",

author = "Tsao, \{Anne S.\} and Lindwasser, \{O. Wolf\} and Adjei, \{Alex A.\} and Adusumilli, \{Prasad S.\} and Beyers, \{Matthew L.\} and Blumenthal, \{Gideon M.\} and Raphael Bueno and Burt, \{Bryan M.\} and Michele Carbone and Dahlberg, \{Suzanne E.\} and \{de Perrot\}, Marc and Fennell, \{Dean A.\} and Joseph Friedberg and Gill, \{Ritu R.\} and Gomez, \{Daniel R.\} and Harpole, \{David H.\} and Raffit Hassan and Mary Hesdorffer and Hirsch, \{Fred R.\} and Julija Hmeljak and Kindler, \{Hedy L.\} and Korn, \{Edward L.\} and Geoffrey Liu and Mansfield, \{Aaron S.\} and Nowak, \{Anna K.\} and Pass, \{Harvey I.\} and Tobias Peikert and Andreas Rimner and Robinson, \{Bruce W.S.\} and Rosenzweig, \{Kenneth E.\} and Rusch, \{Valerie W.\} and Ravi Salgia and Boris Sepesi and Simone, \{Charles B.\} and Rajeshwari Sridhara and Peter Szlosarek and Emanuela Taioli and Tsao, \{Ming Sound\} and Haining Yang and Zauderer, \{Marjorie G.\} and Malik, \{Shakun M.\}",

note = "Publisher Copyright: {\textcopyright} 2018",

year = "2018",

month = nov,

doi = "10.1016/j.jtho.2018.08.2036",

language = "English",

volume = "13",

pages = "1655--1667",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier Inc.",

number = "11",

}

Tsao, AS, Lindwasser, OW, Adjei, AA, Adusumilli, PS, Beyers, ML, Blumenthal, GM, Bueno, R, Burt, BM, Carbone, M, Dahlberg, SE, de Perrot, M, Fennell, DA, Friedberg, J, Gill, RR, Gomez, DR, Harpole, DH, Hassan, R, Hesdorffer, M, Hirsch, FR, Hmeljak, J, Kindler, HL, Korn, EL, Liu, G, Mansfield, AS, Nowak, AK, Pass, HI, Peikert, T, Rimner, A, Robinson, BWS, Rosenzweig, KE, Rusch, VW, Salgia, R, Sepesi, B, Simone, CB, Sridhara, R, Szlosarek, P, Taioli, E, Tsao, MS, Yang, H, Zauderer, MG & Malik, SM 2018, 'Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation', Journal of Thoracic Oncology, vol. 13, no. 11, pp. 1655-1667. https://doi.org/10.1016/j.jtho.2018.08.2036

Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation. / Tsao, Anne S.; Lindwasser, O. Wolf; Adjei, Alex A. et al.
In: Journal of Thoracic Oncology, Vol. 13, No. 11, 11.2018, p. 1655-1667.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Current and Future Management of Malignant Mesothelioma

T2 - A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation

AU - Tsao, Anne S.

AU - Lindwasser, O. Wolf

AU - Adjei, Alex A.

AU - Adusumilli, Prasad S.

AU - Beyers, Matthew L.

AU - Blumenthal, Gideon M.

AU - Bueno, Raphael

AU - Burt, Bryan M.

AU - Carbone, Michele

AU - Dahlberg, Suzanne E.

AU - de Perrot, Marc

AU - Fennell, Dean A.

AU - Friedberg, Joseph

AU - Gill, Ritu R.

AU - Gomez, Daniel R.

AU - Harpole, David H.

AU - Hassan, Raffit

AU - Hesdorffer, Mary

AU - Hirsch, Fred R.

AU - Hmeljak, Julija

AU - Kindler, Hedy L.

AU - Korn, Edward L.

AU - Liu, Geoffrey

AU - Mansfield, Aaron S.

AU - Nowak, Anna K.

AU - Pass, Harvey I.

AU - Peikert, Tobias

AU - Rimner, Andreas

AU - Robinson, Bruce W.S.

AU - Rosenzweig, Kenneth E.

AU - Rusch, Valerie W.

AU - Salgia, Ravi

AU - Sepesi, Boris

AU - Simone, Charles B.

AU - Sridhara, Rajeshwari

AU - Szlosarek, Peter

AU - Taioli, Emanuela

AU - Tsao, Ming Sound

AU - Yang, Haining

AU - Zauderer, Marjorie G.

AU - Malik, Shakun M.

PY - 2018/11

Y1 - 2018/11

N2 - On March 28– 29, 2017, the National Cancer Institute (NCI) Thoracic Malignacy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation convened the NCI–International Association for the Study of Lung Cancer– Mesothelioma Applied Research Foundation Mesothelioma Clinical Trials Planning Meeting in Bethesda, Maryland. The goal of the meeting was to bring together lead academicians, clinicians, scientists, and the U.S. Food and Drug Administration to focus on the development of clinical trials for patients in whom malignant pleural mesothelioma has been diagnosed. In light of the discovery of new cancer targets affecting the clinical development of novel agents and immunotherapies in malignant mesothelioma, the objective of this meeting was to assemble a consensus on at least two or three practice-changing multimodality clinical trials to be conducted through NCI's National Clinical Trials Network.

AB - On March 28– 29, 2017, the National Cancer Institute (NCI) Thoracic Malignacy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation convened the NCI–International Association for the Study of Lung Cancer– Mesothelioma Applied Research Foundation Mesothelioma Clinical Trials Planning Meeting in Bethesda, Maryland. The goal of the meeting was to bring together lead academicians, clinicians, scientists, and the U.S. Food and Drug Administration to focus on the development of clinical trials for patients in whom malignant pleural mesothelioma has been diagnosed. In light of the discovery of new cancer targets affecting the clinical development of novel agents and immunotherapies in malignant mesothelioma, the objective of this meeting was to assemble a consensus on at least two or three practice-changing multimodality clinical trials to be conducted through NCI's National Clinical Trials Network.

KW - Clinical trials

KW - Malignant mesothelioma

KW - Multimodality therapy

KW - Pleural

KW - Targeted therapy

UR - https://www.scopus.com/pages/publications/85055270710

U2 - 10.1016/j.jtho.2018.08.2036

DO - 10.1016/j.jtho.2018.08.2036

M3 - Article

C2 - 30266660

AN - SCOPUS:85055270710

SN - 1556-0864

VL - 13

SP - 1655

EP - 1667

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 11

ER -

Tsao AS, Lindwasser OW, Adjei AA, Adusumilli PS, Beyers ML, Blumenthal GM et al. Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation. Journal of Thoracic Oncology. 2018 Nov;13(11):1655-1667. doi: 10.1016/j.jtho.2018.08.2036